Marjolaine Gauthier-Loiselle

Suggest Changes
Learn More
OBJECTIVE This retrospective observational study assessed if second-line chemotherapy vs. androgen receptor-targeted agents (ARTAs; abiraterone/enzalutamide) is associated with improved outcomes in(More)